China Biologic Products (NASDAQ:CBPO)

GeoProfile
Overview
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders

Do you represent this company?

Learn how we can help increase your exposure to investors.

All Research Potential Valuation Scenarios Acquisition Activity Acquisitions Analyst Reports CFO Trail Comments & Business Outlook Corporate Governance Financials GeoBargain Notes GeoSpecial Notes Investor Alert Investor Presentations Liquidity Requirements Notable Share Transactions

Monday, January 10, 2011

Logic Management Consulting (China) Co., Ltd. entered into an equity transfer agreement, dated January 4, 2011, pursuant to which Logic China agreed to acquire the 10% minority interest in Guiyang Dalin Biologic Technologies Co., Ltd., a limited liability company established under the laws of the People's Republic of China, from Shaowen Fan, for a purchase price of RMB 50 million (approximately $7,530,120).

Permalink